The fellow participates in at least two years of research training. There are a number of opportunities for laboratory and/or clinical research in both the divisions of Hematology and Oncology. The fellow is encouraged to meet with the directors of research hematology and oncology for additional advice, suggestions or guidance in choosing a laboratory. Once the fellow identifies a laboratory mentor, it will be important to formulate a project or proposal that is written, reviewed and approved. There should be a testable hypothesis that addresses some mechanism of disease or cellular or protein function and a plan which outlines specific approaches or experiments to pursue or address this question. The project should have an achievable goal that could be accomplished in the allotted time, allowing time to learn various techniques. The proposal can be a two to three page narrative summary or a summary in the form of a very brief NIH grant proposal. The proposal should also include relevant references from the field as well as the mentor but should not be extensive. After the completion of the project, the fellow will prepare a manuscript suitable for publication.
Additional training or educational experience include attending at least one national meeting during the first and second year of laboratory training. Another option is to attend one of a variety of intensive, hands-on workshops (e.g., Cold Spring Harbor Courses, the AACR Molecular Biology of Clinical Oncology Workshop) during the third year.
Fellows interested in pursuing clinical research usually complete a Master's level curriculum in order to fulfill the requirements for the Hematology/Oncology Fellowship. This will include attending a number of core and elective courses over a two-year period, as well as the design and execution of a clinical project in conjunction with the Hematology/Oncology mentor and a mentor from the Master's program. The Master's degree programs include Epidemiology and Biostatistics, Genetic Epidemiology, Health Sciences/Outcomes Research, Cancer Pharmacology and Experimental Therapeutics or other areas. Pursuit of these programs will require review by a selection committee and acceptance into the program.
For non-urgent questions or requests